OST-HER2 and the Fight Against Osteosarcoma: A New Hope After 40 Years

Join us as we sit down with Paul Romness of OS Therapies to explore an exciting breakthrough in OST-HER2 targeted therapies for osteosarcoma —a rare and aggressive bone cancer. Learn how this innovative approach is offering new hope to patients, advancing precision medicine, and pushing the boundaries of rare disease treatment, not just for humans but for dogs too. Joining the discussion as always is host Owen Bryant, along with George Rack and guest presenter and P4A's MA Oncology expert, Rosa Faria Matthews. Don’t miss this powerful conversation on the frontlines of rare cancer research. Tune in now—because every rare voice matters.

You can listen to OST-HER2 and the Fight Against Osteosarcoma: A New Hope After 40 Years online on Radio and Podcast. Open the player on this page to stream the available audio.

OST-HER2 and the Fight Against Osteosarcoma: A New Hope After 40 Years is an episode from Rare Disease, Cell & Gene Therapy Monthly RoundUp by Partners4Access.

This episode is 00:27:44 long.

This episode was published on Jul 1, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Rare Disease, Cell & Gene Therapy Monthly RoundUp when more episodes are available from the podcast feed.